EU Stoxx 50 May Fall Despite Approval of Moderna Covid-19 Vaccine

Europe’s benchmark EU Stoxx 50 index may lose ground in the coming days despite the regulatory approval of Moderna’s Covid-19 vaccine as price runs into key resistance.

from DailyFX – Market News https://bit.ly/2L8znKU
via IFTTT

from WordPress https://bit.ly/2JQksnV
via IFTTT

from Blogger https://bit.ly/2LdMpGV
via IFTTT

from WordPress https://bit.ly/2L0wLij
via IFTTT

from Blogger https://bit.ly/2JRPrjw
via IFTTT